Divis Laboratories Ltd

  • BSE Code : 532488
  • NSE Symbol : DIVISLAB
  • ISIN : INE361B01024
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS

up-arrow 3,929.00 18.25(0.47%)

Open Price ()

3,887.05

Prev. Close ()

3,910.75

Volume (No’s)

31,964

Market Cap ()

104,302.61

Low Price ()

3,870.00

High Price ()

3,965.00

 

Corporate Announcement

15-May-2024 Divi's Laboratories Limited - Board Meeting
25-Apr-2024 Divi's Laboratories Limited - Updates
09-Apr-2024 Divi's Laboratories Limited - Other General Purpose
08-Apr-2024 Divi's Laboratories Limited - Copy of Newspaper Publication
05-Apr-2024 Divi's Laboratories Limited - Shareholders meeting

Stock Summary

Market Cap(₹Cr.)

104,234.91

P/E (TTM)

76.42

Book value ()

474.52

Div Yield (%)

0.76

EPS (TTM)

51.38

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

3,945.10

Resistance 2

3,979.45

Support 1

3,886.00

Support 2

3,861.25

Moving Average

30 Days

3,838.77

50 Days

3,702.47

100 Days

3,722.47

200 Days

3,692.18

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Divis Laboratories Ltd 104,234.91 76.42 5.9 2697.86 0.76 51.38
Sun Pharmaceuticals Indus.. 367,290.20 89.16 9.93 3814.1 0.75 17.17
Cipla Ltd 113,350.18 30.52 2.95 4107.41 0.61 46
Zydus Lifesciences Ltd 111,133.51 41.35 3.65 2799 0.27 26.71
Dr Reddys Laboratories Lt.. 97,001.49 22.34 3.74 4806.1 0.69 260.28

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of

in Months Ago

My investment would be worth 95,664.50 with a Loss of -4.34%

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 40620698 15.30
Total Institutions 58962628 22.21
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 3602080 1.36
Total Promoters 137833600 51.92
Total Public & others 24449574 9.21
Total 265468580 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries. It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. It is among the largest pharmaceutical companies in India with a portfolio of approx. 160 products across diverse therapeutic areas. Presently, it has 6 manufacturing facilities and market presence across several countries.

The company has two subsidiaries M/s. Divis Laboratories (USA) Inc., in the United States of America and M/s. Divi's Laboratories Europe AG in Switzerland for marketing its Nutra products and to provide a greater reach to customers within these regions. The company has Research Centers at Sanathnagar, Hyderabad and at the manufacturing sites. Resear...

Copyright © 2019 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)